RAFAEL HOLDINGS, INC. Public Float
RAFAEL HOLDINGS, INC. (RFL) had Public Float of $38.60 million as of 2025-01-31, per its 10-K filed 2025-10-29.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2025-10-29
- 2025-01-31: Entity Public Float $38.60M.
- 2024-01-31: Entity Public Float $34.40M.
- 2023-01-31: Entity Public Float $70.20M.
- 2022-01-31: Entity Public Float $70.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-01-31 | $38.60M 10-K · filed 2025-10-29 |
| 2024-01-31 | $34.40M 10-K/A · filed 2025-01-08 |
| 2023-01-31 | $70.20M 10-K · filed 2023-10-30 |
| 2022-01-31 | $70.20M 10-K · filed 2022-10-31 |
| 2021-01-29 | $330.20M 10-K · filed 2021-10-18 |
| 2020-01-31 | $183.50M 10-K · filed 2020-10-29 |
| 2019-01-31 | $96.00M 10-K · filed 2019-10-04 |
| 2018-01-31 | $0.00 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |